Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Am J Respir Crit Care Med ; 149(6): 1570-4, 1994 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8004315

RESUMEN

To determine the predominant abnormality of pulmonary function in patients with thalassemia major (TM), we evaluated 29 patients with TM who were receiving hypertransfusion therapy and chelation with desferrioxamine (DFO), and who ranged in age from 6 to 40 yr (mean 19.8 +/- 8.5 yr). A reduction in the total lung capacity (TLC) was the most striking abnormality, found in 21 of 29 patients (79%). Fourteen of these patients (67%) had a moderate or severe reduction in TLC. Expiratory flow rates, FEV1, and FEF25-75 were decreased below predicted values in 48 and 17% of the patients, respectively, but no patients had pure obstructive disease. Significant hypoxemia (oxygen saturation of less than 95%) was observed in only one patient. There was a significant inverse correlation between TLC and patient age (p < 0.003), transfusional iron burden (p < 0.003) and DFO ratio (p < 0.024). Restrictive disease is the predominant abnormality of pulmonary function in TM, with a mixed restrictive-obstructive pattern in a small number of patients. The restrictive disease becomes more severe with increasing age, and the degree and duration of iron overload appear to be important in its pathogenesis. The role of DFO therapy in preventing the pulmonary complications associated with TM requires further study.


Asunto(s)
Deferoxamina/uso terapéutico , Hierro/efectos adversos , Enfermedades Pulmonares Obstructivas/etiología , Enfermedades Pulmonares Obstructivas/fisiopatología , Mediciones del Volumen Pulmonar , Reacción a la Transfusión , Talasemia beta/complicaciones , Talasemia beta/terapia , Adolescente , Adulto , Factores de Edad , Análisis de los Gases de la Sangre , Carga Corporal (Radioterapia) , Niño , Femenino , Ferritinas/sangre , Humanos , Modelos Lineales , Enfermedades Pulmonares Obstructivas/sangre , Enfermedades Pulmonares Obstructivas/diagnóstico , Enfermedades Pulmonares Obstructivas/epidemiología , Enfermedades Pulmonares Obstructivas/prevención & control , Masculino , Oxígeno/sangre , Índice de Severidad de la Enfermedad
2.
Genetika ; 24(4): 763-5, 1988 Apr.
Artículo en Ruso | MEDLINE | ID: mdl-3294106

RESUMEN

Raising total positive charge of a chemical mutagen does increase its local concentration in the area of biological target-DNA, and, as a consequence, causes increase in the rate of interaction of a mutagen with the target. Experimental evidence of this idea has been obtained in three test systems: the Ames test, Trp+ reversions in Escherichia coli WP2 and in the automated "SOS-chromotest" system with E. coli PQ 37 ("Labsystems", Finland).


Asunto(s)
Aziridinas/toxicidad , Azirinas/toxicidad , Reparación del ADN , Mutágenos , Respuesta SOS en Genética , Escherichia coli/genética , Pruebas de Mutagenicidad , Salmonella typhimurium/genética , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA